Objective To assess whether prolonged neonatal cholestasis, described in congenital hypopituitarism and septooptic dysplasia (SOD), is associated with altered expression of selected canalicular ectoenzymes and canalicular transport proteins.
Results Patients presented at a median age of 8 weeks (range 3-20 weeks) with median total bilirubin 116 µmol/L (45-287 µmol/L), GGT 95 IU/L (25-707 UI/L), and serum cortisol 51 nmol/L (17-240 nmol/L). All but 3 had low free thyroxin (median 9.6 pmol/L [6.8-26 .9]) with increased thyroid-stimulating hormone levels (median 5.95 mU/L [<0. 1-9.24] ). Liver histologic features included moderate-to-severe intralobular cholestasis with nonspecific hepatitis, giantcell transformation of hepatocytes, and fibrosis. In all, immunohistochemical staining for canalicular ectoenzymes and canalicular transport proteins revealed a degree of reduced expression, associated with normal serum GGT values in 6 of the 10 patients, and another 6 nonbiopsied infants with cholestasis also had low/normal serum GGT activity. Sequencing of ABCB11 and ATP8B1 performed in 6 of the biopsied patients did not identify pathogenic mutations. Following replacement therapy, biochemical evidence of hepatobiliary injury resolved in all children within a median period of 6 months. T he association of liver dysfunction with congenital hypopituitarism was first suggested by de Morsier in 1956. 1 Several series of patients with congenital hypopituitarism, with or without septo-optic dysplasia (SOD), and mixed (conjugated and unconjugated) hyperbilirubinemia have been described. [2] [3] [4] [5] [6] [7] [8] [9] Reported liver biopsy findings in these patients are nonspecific, with intralobular cholestasis, mild portal inflammation, and/or giant-cell transformation of hepatocytes. Following replacement therapy with hydrocortisone and often thyroxin, clinical and biochemical evidence of hepatobiliary injury typically resolves. Failure to initiate early treatment can exceptionally lead to cirrhosis and subsequent liver transplantation. 9 The causal relationship between endocrine abnormalities and cholestasis, however, remains poorly understood.
Conclusion
Clinical features suggestive of congenital hypopituitarism include hypoglycemia, hypothermia, ambiguous genitalia, and electrolyte imbalance."Soft" dysmorphic facial features (frontal bossing, depressed nasal bridge, and saddle-shaped nose) are described. 9, 10 Reported ocular abnormalities in SOD vary from poor visual acuity to complete blindness due to optic nerve dysplasia or atrophy. Brain defects associated with SOD include hypophyseal hypoplasia and midline brain abnormalities, such as absence of the corpus callosum and/or septum pellucidum.
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Some of our patients with cholestasis and congenital hypopituitarism had serum g-glutamyltransferase (GGT) activity levels either normal or disproportionately low for the degree of conjugated hyperbilirubinemia present. The canalicular transport protein bile salt export pump (BSEP) and several canalicular ectoenzymes may be abnormally expressed in various forms of intrahepatic cholestasis that are associated with normal-range ("low") GGT activity. We hypothesized that canalicular antigens might be expressed abnormally in congenital hypopituitarism. The clinical phenotypes described in the previous series, owing to mutation in ATP8B1 or ABCB11, vary substantially within and between familial intrahepatic cholestasis type 1 (FIC1) deficiency and BSEP deficiency. They range from mild, episodic cholestasis and pruritus ("benign" recurrent intrahepatic cholestasis) to end-stage chronic liver disease requiring liver transplantation. [12] [13] [14] [15] Clinical variation occurs even among patients with the same mutations, suggesting that factors other than the mutations themselves may influence the expression or function of canalicular ectoenzymes and canalicular transport proteins, as observed with transient neonatal cholestasis 16, 17 or perturbations in hormonal milieu (pregnancy, oral contraceptive use) that could precipitate cholestasis in previously asymptomatic individuals who harbor polymorphisms in ATP8B1 or ABCB11. 18, 19 We thought it was conceivable that ATP8B1 or ABCB11 variation might conduce intrahepatic cholestasis in congenital hypopituitarism. Accordingly, we immunohistochemically evaluated canalicular ectoenzyme and canalicular transport protein expression in patients with congenital hypopituitarism and normal ("low") serum GGT activity despite cholestasis.
Methods
Approximately 150 infants with liver disease are referred annually to the tertiary-care pediatric liver center at King's College Hospital, London. A retrospective analysis of the patient database from 1990 to 2016 was undertaken to identify children with neonatal cholestasis associated with congenital hypopituitarism.
Infants referred for the investigation of prolonged conjugated jaundice undergo clinical, biochemical, and radiologic evaluation, often including percutaneous liver biopsy. Initial endocrine investigations include determinations of random serum concentrations of glucose, cortisol, thyroid-stimulating hormone, and free thyroxin. Children with random serum cortisol values <100 nmol/L routinely undergo short adrenocorticotropic hormone (ACTH; "Synacthen," Mallinckrodt Specialty Pharmaceuticals Ireland Ltd, Dublin, Ireland) testing (intramuscular injection of 62.5 µg followed by measurement of cortisol levels at 0, 30, and 60 minutes) and detailed ophthalmologic examination for signs of SOD. If findings on ACTH testing are abnormal, cranial magnetic resonance imaging 20 is performed to look for anatomic abnormalities of the pituitary gland and optic nerves.
Percutaneous liver biopsy is performed when the etiology of cholestasis cannot be established on the basis of noninvasive tests. Normal-range or "low" GGT activity in some infants prompts immunohistologic study of expression of canalicular transport proteins and canalicular ectoenzymes, including GGT, in the liver biopsy material. In the present work, immunohistologic evaluation was performed retrospectively ( Table I) .
Archived liver biopsy specimens were available from 10 patients. Tissue sections cut at 4 µm were stained with hematoxylin-eosin and, after diastase digestion, with the periodic acid-Schiff technique. In addition, parallel sections were immunostained (ChemMate; DAKO, Ely, United Kingdom) with a privately generated rabbit polyclonal antibody against a peptide with the sequence of C-terminal BSEP 21 and with mouse monoclonal antibodies against epitopes of the homologous ATP-binding cassette canalicular transporters multidrug resistance protein 2 (MRP2; clone M2III6; Signet/Bioquote, York, United Kingdom) and multidrug resistance protein 3 (MDR3; ALX-801-028; Alexis Biochemicals, Nottingham, United Kingdom) as well as for the ectoenzymes alanyl aminopeptidase (CD13; Novocastra NCL-CD13-304, mouse monoclonal, clone 38C12; Vector Laboratories, Newcastle-uponTyne, United Kingdom) and GGT (Abnova H00002678-M01, mouse monoclonal, clone 1F9; Novus Biologicals, Cambridge, United Kingdom). All commercial products were used according to manufacturers' instructions.
Stored consented blood samples were available for 6 patients. DNA was extracted from stored leucocyte-pellet samples (−80°C). Sanger sequencing was performed for all exons, with exon-intron junctions of ABCB11 22 and ATP8B1.
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Results
Twenty-one patients (12 male, 57%) with the diagnosis of congenital hypopituitarism were identified. All patients were born 
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by spontaneous vaginal delivery; all but 2 were born at term (patients 9 and 13 at 27 and 31 weeks of gestation, respectively). Median birth weight was 2.2 kg (range 0.975-4.3 kg).
The antenatal history was unremarkable in all, apart from patient 13, whose mother had abused cocaine and who developed neonatal abstinence syndrome. Median age at admission for evaluation of prolonged conjugated jaundice was 8 weeks (range 2-20 weeks). Seven (33%) children were referred during the first month of life. Percutaneous liver biopsy was performed in 10 children. None of the patients had a family history of endocrine disorder, consanguinity, or developmental problems. All other causes of prolonged neonatal conjugated hyperbilirubinemia were excluded. ;  Table II ) had normal serum GGT activity for age and sex. 23 All patients except 7, 10, 17, and 21 had abnormal random serum cortisol concentrations, median 51 nmol/L (range 18-240; Table III ). These 4 infants with normal baseline serum cortisol values had abnormal thyroid function tests and thus went on to undergo ACTH testing. All but patients 4, 15, and 16 had abnormal serum thyroid-stimulating hormone concentrations; 12 of these patients had low serum free thyroxin concentrations.
Clinical Findings
Magnetic resonance imaging assessment of the pituitary gland and optic nerves was performed in all patients except 5 and 12. Among the 19 patients who underwent brain imaging, all but 2 (1, 10) had pituitary gland abnormalities. In some (n = 3), the pituitary stalk was absent, and in some (n = 2), the sella turcica was small and the pituitary fossa was shallow, optic nerves were atrophic (n = 11), and the neurohypophysis was small (n = 13). Some patients had more than 1 abnormality. Imaging in patient 10 was normal. In patient 1 the anterior pituitary appeared normal, but ectopic pituitary tissue lay dorsal to the optic chiasm. All patients underwent ophthalmologic examination, with dysplastic or aplastic changes of the optic disc diagnosed in 11 (52%). The 18 patients diagnosed with congenital hypopituitarism and hypothyroidism were started on treatment with hydrocortisone (2.5 mg 3 times/d) and thyroxin (25 µg/d). Three patients with normal thyroid function were given only hydrocortisone (2.5 mg 3 times/d). In the second year of life, growth hormone supplementation therapy (25 µg/kg/d) was started in 14 of the 21 patients because of poor linear growth. The median time for serum aspartate aminotransferase and bilirubin levels to normalize was 6 months (range 3-9 months). None of the patients had clinical or ultrasonographic signs of liver disease during follow-up, and no further liver biopsies were performed.
The liver biopsy findings included moderate-to-severe degrees of cellular and canalicular cholestasis in all cases, with prominent multinucleated giant-cell transformation in most of them. The portal tracts were mildly expanded due to mixed inflammatory cell infiltrates and fibrosis, and the parenchyma had occasional hemopoietic foci, patchy hepatocyte necrosis, marked siderosis of macrophages and some scattered fatty vacuoles ( Table I) .
On immunostaining, CD13 was expressed at apices of cholangiocytes and along canalicular margins. Expression of MRP2 was reduced in patients 5 and 8 and less widespread than that of CD13 (Figure) . There was markedly reduced expression of GGT in 5 of 7 patients. Expression of BSEP was present along the canaliculi (Figure) , but in all patients it was only focal and was less strong than in age-matched controls (Table III) . MDR3 immunostaining was present along canalicular margins, although its expression was considerably weaker and less widespread than that of MRP2 except in patients 5 and 8. Controls marked appropriately.
In view of the reduced expression of canalicular transport proteins and GGT on immunostaining, genetic screening was undertaken to exclude a genetic cause of cholestasis. Sanger sequencing of all exons of ABCB11 and ATP8B1, performed on patients 1, 3, 4, 7, 8, and 10, in whom DNA was available, identified no mutations.
Discussion
We note that 57% of these infants with cholestasis and primary congenital hypopituitarism have low or normal serum GGT. We infer that congenital hypopituitarism could underlie intrahepatic cholestasis, rather than simply coexisting with it, from the observed resolution of cholestasis with corticosteroid and thyroxin therapy. Our findings suggest that cortisol and thyroxin may be required for normal hepatocellular expression of canalicular transport proteins such as BSEP, MDR3, and MRP2 as well as of canalicular ectoenzymes such as GGT.
Our series documented an incidence of congenital hypopituitarism in 1% of infants with conjugated hyperbilirubinemia referred to a specialized pediatric hepatology center. This prevalence is lower than the 5% reported in general pediatric single-center series. 2, 24 The incidences of congenital hypopituitarism and SOD in the general pediatric population are reported as 1 in 100 000 25 and 10.9 in 100 000, 26 respectively. Infants with primary adrenal insufficiency vary in severity of cholestasis, although isolated ACTH deficiency (secondary hypoadrenalism) has not been documented in patients with cholestasis. 2, 5 We observed a slight male prevalence in children with SOD from our series, as 8 (73%) of 11 infants with ocular involvement were boys, whereas among the remaining 10, only 4 (40%) were male. In a similar series, 4 of 8 patients 9 and 3 of 5 4 patients with SOD were male.
Once supplementation with hydrocortisone and thyroxin was initiated, liver impairment started to improve in all patients within the first 9 months of life. Spray et al reported that biochemical indices of hepatobiliary injury normalized in 7 of 12 infants within 6 weeks of initiating such supplementation. 9 We could not identify any difference between the children with congenital hypopituitarism with and without SOD with respect to severity of liver disease or length of time required to clear jaundice.
Fourteen patients in our series required growth hormone in the second year of life, when biochemical signs of liver dysfunction already had disappeared. This contrasts with findings in some previous studies, 11, 24 including an early report describing 1 infant, diagnosed in the neonatal period with growth hormone deficiency, who despite treatment with hydrocortisone had ongoing liver injury on liver biopsy at age 2 years, demonstrating prominent fibrosis and a micronodular distortion of lobular architecture. 5 It may be speculated that this infant had, in addition to growth hormone deficiency, another underlying liver disorder not appreciated at the time.
Histologic signs of liver injury in our patients were relatively mild and nonspecific and included hepatocellular and canalicular cholestasis, mild portal-tract inflammation, and giant-cell transformation of hepatocytes. As subsequent biopsies were unjustified in the absence of clinical and biochemical signs of liver disease, we can only speculate that the initial histologic damage was temporary. Minami et al have described a 7-year-old girl with congenital hypopituitarism and SOD in whom liver biopsy findings were interpreted as congenital hepatic fibrosis. 27 This may have been coincidence; none of our 10 patients who had a biopsy had histologic features of ductal plate malformation, and none of our 21 patients has clinical signs of chronic liver disease or portal hypertension during follow-up.
Some infants with conjugated hyperbilirubinemia have serum GGT levels that are either normal or inappropriately low. Some such patients harbor mutations in ATP8B1, encoding an enzyme that shifts aminophospholipids from the external to the internal hemileaflet of the bile-canaliculus membrane (FIC1). The resulting lack of hemimembrane symmetry destabilizes the membrane, a phenomenon associated with decreased expression of canalicular ectoenzymes, including GGT. 28, 29 Without GGT expression, bile salts cannot excrete GGT into the bile,
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Figure. A, Liver biopsy specimen demonstrating a giant-cell hepatitis with canalicular cholestasis (patient 2, hematoxylin-eosin ×200 magnification, scale bar = 50 µm). The inset shows an age-matched control with alpha-1 antitrypsin deficiency, PiZZ (Periodic acid-Schiff-diastase stain ×400 magnification, black arrows indicating the DPAS-positive globules in periportal hepatocytes, scale bar = 20 µm). B, Immunostaining with CD13 (patient 2, main image ×200 magnification, scale bar = 50 µm) demonstrated maintained canalicular CD13 expression comparable with that seen in periportal hepatocytes in an age-matched patient with alpha-1 antitrypsin deficiency (upper inset, ×400 magnification, scale bar = 20 µm) and in an age-matched healthy control (lower inset, ×400 magnification, scale bar = 20 µm). C, MRP2 immunostaining (patient 2, MRP2, main image ×200 magnification, scale bar = 50 µm) demonstrated maintained canalicular expression comparable with that seen in periportal hepatocytes in an agematched control patient with alpha-1 antitrypsin deficiency (upper inset, ×400 magnification, scale bar = 20 µm) and in an agematched healthy control (lower inset, ×400 magnification, scale bar = 20 µm). D, There was markedly reduced expression of GGT (patient 2 main image ×200 magnification, scale bar = 50 µm) compared with periportal hepatocytes in an age-matched patient with alpha-1 antitrypsin deficiency (upper inset, ×400 magnification, scale bar = 20 µm) and in an age-matched control (lower inset, GGT ×400 magnification, scale bar = 20 µm). E, Only focal punctate canalicular expression of BSEP was seen (patient 2, main image, BSEP with arrows indicating BSEP expression, ×400 magnification, scale bar = 20 µm) compared with periportal hepatocytes in an age-matched patient with alpha-1 antitrypsin deficiency (upper inset ×400 magnification, scale bar = 20 µm) and an age-matched control (lower inset, BSEP ×400 magnification, scale bar = 20 µm). F, Focal punctate canalicular MDR3 expression also was seen (patient 2, MDR3, main image, arrows indicate canalicular expression, ×400 magnification, scale bar = 20 µm) compared with periportal hepatocytes in an age-matched control with alpha-1 antitrypsin deficiency (upper inset, MDR3 ×400 magnification, scale bar = 20 µm) and in a healthy control (lower inset, MDR3 × 400 magnification, scale bar = 20 µm).
from where it refluxes into plasma (with its activity measured in serum). Others have mutations in ABCB11, encoding BSEP, which transfers amino acid conjugates of bile acids from cytoplasm of hepatocytes into the canalicular lumen. 21 In this setting BSEP expression may be deficient, whereas expression of other canalicular transport proteins and of canalicular ectoenzymes is intact. Consequently, due to the lack of bile salts, GGT cannot be leached into bile. The same holds for disorders of bile acid synthesis or conjugation, in which substrates suitable for BSEP are not produced or lack hydrophilicity sufficient to guard against loss of bile acids from bile through canalicular tight junctions [30] [31] [32] ; without bile salts in the bile, GGT elution cannot proceed. 33 Finally, disorders of intracellular trafficking may lead to abnormal expression of canalicular ectoenzymes and canalicular transport proteins alike, a setting in which deficiency in both GGT and BSEP expression as well as in BSEP function likely contribute to failure of serum GGT activity to increase. 28, 34, 35 The morphologic appearances of the biopsy specimens in our study were more typical of those seen in FIC1 disease in the form of giant-cell hepatocyte change. The morphologic appearances in the biopsy specimens and reduction in intensity of staining of both GGT and BSEP seen in this cohort suggest a combination of pathophysiologic mechanisms affecting both expression of canalicular ectoenzyme/canalicular transport protein, membrane stability, and bile acid homeostasis contributing to this phenotype rather than the phenotype being secondary to a single underlying canalicular ectoenzyme/ canalicular transport protein defect.
We investigated the expression of canalicular transport proteins and canalicular ectoenzymes, including GGT, in the liver after observing low or normal serum levels of GGT activity in more than one-half of our study cohort with clinically documented congenital hypopituitarism. Indeed, immunohistochemical analysis suggested deficiency of hepatocellular expression of some canalicular transport proteins, in particular BSEP. Transient intrahepatic cholestasis in a newborn infant has been reported in association with heterozygosity for a deletion affecting the ABCB11 locus, identified by fluorescence in situ hybridization analysis. 36 In our patient cohort, no ABCB11 mutations were found in the 6 patients analyzed (among 10 biopsied).
Our observation could indicate that corticosteroid and thyroxin sufficiency are important for bile flow at this age. Indeed, the histologic features observed in this series are reminiscent of, albeit milder than, the findings in the liver biopsy specimens at presentation from children with mutation-proven ABCB11 disease and immunohistochemically demonstrated BSEP deficiency. Expression of CD13, serving as a control marker, was robust in all specimens, identifying canaliculi along with cholangiocyte apices throughout the biopsy material.
Shortcomings of our study were limited number of infants who had liver biopsy, as often this procedure is not strongly indicated in presence of confirmed congenital hypopituitarism and SOD. In addition, not all patients who underwent a biopsy procedure had stored DNA for retrospective mutational analysis. Finally, recent studies have revealed additional genetic causes of low GGT cholestasis, such as tight junction protein 2 deficiency 37 and myosin 5B deficiency, 37 which were not tested for in this analysis due to lack of DNA. A mechanism linking cholestasis with adrenal and thyroid insufficiency in congenital hypopituitarism remains uncertain. Isolated primary hypothyroidism typically is associated with unconjugated hyperbilirubinemia, 38 suggesting that deficiency not of thyroid hormones but rather of corticosteroid hormones could be responsible for the conjugated jaundice observed in primary congenital hypopituitarism. In normal liver, corticosteroids could enhance bile output by increasing the bile salt-independent fraction of bile flow, 39 probably inducing an increase in Na − exchanger (AE2 member) activity, resulting in an increase in bicarbonate excretion. 40 Corticosteroids have been used empirically to improve cholestasis in a number of cholestatic conditions. [41] [42] [43] [44] [45] For example, low-dose prednisolone (2 mg/ kg/d) improves cholestasis in younger infants with biliary atresia following hepatic portoenterostomy but with no discernible effect on eventual outcome. 41, 46 Whether the beneficial effects of the steroids on cholestasis could be related to their inducing expression of canalicular transport proteins or canalicular ectoenzymes at bile canaliculi remains speculative.
Our study suggests that endocrine mechanisms could be involved in the aberrant expression of canalicular transport proteins during prolonged neonatal cholestasis associated with primary congenital hypopituitarism. This observation may have some implications for other cholestatic conditions and warrants further study using more sophisticated molecular methods for the assessment of expression of canalicular transport proteins in a larger number of patients. ■ Submitted for publication Dec 9, 2017; last revision received Apr 12, 2018; accepted May 5, 2018 
